CAD 0.2
(14.29%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2022 | 373 Thousand CAD | 52.87% |
2021 | 244 Thousand CAD | 0.0% |
2019 | 3.11 Million CAD | -65.93% |
2018 | 9.14 Million CAD | -39.62% |
2017 | 15.14 Million CAD | 0.42% |
2016 | 15.08 Million CAD | -37.63% |
2015 | 24.18 Million CAD | -2.9% |
2014 | 24.9 Million CAD | -11.09% |
2013 | 28 Million CAD | 34.26% |
2012 | 20.85 Million CAD | -28.39% |
2011 | 29.13 Million CAD | 103.43% |
2010 | 14.31 Million CAD | 765.48% |
2009 | 1.65 Million CAD | 2.6% |
2008 | 1.61 Million CAD | 4810.11% |
2007 | 32.84 Thousand CAD | 317.8% |
2006 | 7861.00 CAD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 Q1 | 460 Thousand CAD | 23.32% |
2023 Q3 | 5.38 Million CAD | 26.78% |
2023 Q2 | 4.24 Million CAD | 822.83% |
2022 FY | 373 Thousand CAD | 52.87% |
2022 Q1 | 225 Thousand CAD | -7.79% |
2022 Q2 | 206 Thousand CAD | -8.44% |
2022 Q3 | 194 Thousand CAD | -5.83% |
2022 Q4 | 373 Thousand CAD | 92.27% |
2021 Q4 | 244 Thousand CAD | -69.69% |
2021 Q3 | 805 Thousand CAD | 85.91% |
2021 Q1 | 491 Thousand CAD | 0.0% |
2021 FY | 244 Thousand CAD | 0.0% |
2021 Q2 | 433 Thousand CAD | -11.81% |
2020 Q1 | 3.11 Million CAD | -59.39% |
2020 Q3 | 3.27 Million CAD | -2.36% |
2020 Q2 | 3.34 Million CAD | 7.51% |
2019 Q1 | 9.14 Million CAD | -47.16% |
2019 Q3 | 8.89 Million CAD | -9.74% |
2019 Q4 | 7.67 Million CAD | -13.81% |
2019 FY | 3.11 Million CAD | -65.93% |
2019 Q2 | 9.85 Million CAD | 7.82% |
2018 Q1 | 15.14 Million CAD | 4.61% |
2018 Q4 | 17.3 Million CAD | 4.22% |
2018 Q2 | 16.29 Million CAD | 7.59% |
2018 Q3 | 16.6 Million CAD | 1.91% |
2018 FY | 9.14 Million CAD | -39.62% |
2017 Q2 | 14.58 Million CAD | -3.31% |
2017 FY | 15.14 Million CAD | 0.42% |
2017 Q1 | 15.08 Million CAD | 17.82% |
2017 Q3 | 15.05 Million CAD | 3.25% |
2017 Q4 | 14.47 Million CAD | -3.85% |
2016 FY | 15.08 Million CAD | -37.63% |
2016 Q4 | 12.8 Million CAD | -21.37% |
2016 Q3 | 16.27 Million CAD | -37.06% |
2016 Q2 | 25.86 Million CAD | 6.95% |
2016 Q1 | 24.18 Million CAD | -3.3% |
2015 Q3 | 21.7 Million CAD | 3.87% |
2015 FY | 24.18 Million CAD | -2.9% |
2015 Q2 | 20.89 Million CAD | -16.08% |
2015 Q1 | 24.9 Million CAD | 20.02% |
2015 Q4 | 25 Million CAD | 15.2% |
2014 Q3 | 20.37 Million CAD | 7.07% |
2014 Q2 | 19.03 Million CAD | -32.05% |
2014 FY | 24.9 Million CAD | -11.09% |
2014 Q1 | 28 Million CAD | -2.56% |
2014 Q4 | 20.74 Million CAD | 1.83% |
2013 Q1 | 20.85 Million CAD | 50.05% |
2013 FY | 28 Million CAD | 34.26% |
2013 Q4 | 28.74 Million CAD | 2.1% |
2013 Q3 | 28.15 Million CAD | 19.45% |
2013 Q2 | 23.56 Million CAD | 12.98% |
2012 Q4 | 13.9 Million CAD | -15.85% |
2012 Q2 | 17.76 Million CAD | -39.03% |
2012 Q3 | 16.52 Million CAD | -6.99% |
2012 Q1 | 29.13 Million CAD | 357.19% |
2012 FY | 20.85 Million CAD | -28.39% |
2011 Q1 | 14.31 Million CAD | 73.7% |
2011 Q2 | 8.57 Million CAD | -40.09% |
2011 Q3 | 3.61 Million CAD | -57.9% |
2011 Q4 | 6.37 Million CAD | 76.42% |
2011 FY | 29.13 Million CAD | 103.43% |
2010 Q4 | 8.24 Million CAD | 6.54% |
2010 Q1 | 1.65 Million CAD | 0.21% |
2010 Q3 | 7.73 Million CAD | 93.7% |
2010 FY | 14.31 Million CAD | 765.48% |
2010 Q2 | 3.99 Million CAD | 141.45% |
2009 Q3 | 939.02 Thousand CAD | -8.97% |
2009 FY | 1.65 Million CAD | 2.6% |
2009 Q4 | 1.65 Million CAD | 75.82% |
2009 Q2 | 1.03 Million CAD | -36.03% |
2009 Q1 | 1.61 Million CAD | -66.95% |
2008 Q1 | 32.84 Thousand CAD | 23.37% |
2008 Q3 | 28.06 Thousand CAD | -19.32% |
2008 Q2 | 34.79 Thousand CAD | 5.93% |
2008 FY | 1.61 Million CAD | 4810.11% |
2008 Q4 | 4.87 Million CAD | 17282.43% |
2007 Q4 | 26.62 Thousand CAD | -16.23% |
2007 Q3 | 31.78 Thousand CAD | 280.05% |
2007 FY | 32.84 Thousand CAD | 317.8% |
2007 Q2 | 8362.00 CAD | 0.0% |
2006 FY | 7861.00 CAD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
MustGrow Biologics Corp. | 1.35 Million CAD | 72.444% |